メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Tacrolimus attenuates Th17 cell-mediated allergic skin inflammation in mice

  • Fatemeh Beygom Mirkatouli
  • , Yukiko Tao
  • , Uyanga Enkhbaatar
  • , Ryoken Yamanaka
  • , Kento Miura
  • , Norimasa Yamasaki
  • , Sawako Ogata
  • , Naohisa Hosomi
  • , Akio Mori
  • , Tomoharu Yasuda
  • , Masaya Matsuda
  • , Yuya Sannomiya
  • , Takeshi Nabe
  • , Tomofumi Numata
  • , Kazumitsu Sugiura
  • , Noriko Kitamura
  • , Minoru Gotoh
  • , Osamu Kaminuma

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

1   !!Link opens in a new tab 被引用数 (Scopus)

抄録

Tacrolimus, a topical calcineurin inhibitor, is used to treat atopic dermatitis (AD). AD is classically T helper type (Th) 2-driven, but Th17 cells are implicated in chronic AD, yet its efficacy against Th17-dependent pathology remains unclear. We investigated the effects of tacrolimus using a murine model of Th17-mediated allergic skin inflammation. In CD4+T cells from DO11.10/Rag2−/−mice, which express ovalbumin (OVA)-specific T cell receptor, tacrolimus differentially suppressed stimulation-induced cytokine expression by Th2 cells. At similar concentrations, tacrolimus suppressed Il21, but not Il17a or Il22, expression in Th17 cells. Subcutaneous OVA challenge elicited ear thickening in BALB/c mice after adoptive transfer of Th2 or Th17 cells, with a stronger response in Th17-transferred mice, but less than OVA-immunized controls. Topical tacrolimus reduced Th17-mediated ear swelling, corroborated by histopathology. In Th2-transferred mice, tacrolimus tended to reduce early skin thickening (day 3) but did not affect late responses (day 7). In Th17-transferred mice, tacrolimus significantly reduced allergen-specific T-cell accumulation in OVA-injected skin and tended to reduce Il21 expression, whereas Th2-cell accumulation and cytokine expression were unaffected. Tacrolimus exerts stronger inhibitory effects on Th17- than Th2-driven responses in this model, suggesting that suppression of Th17 pathways may contribute to its therapeutic benefit in AD.

本文言語英語
ページ(範囲)152-157
ページ数6
ジャーナルJournal of Pharmacological Sciences
巻160
号3
DOI
出版ステータス出版済み - 03-2026

All Science Journal Classification (ASJC) codes

  • 分子医療
  • 薬理学

フィンガープリント

「Tacrolimus attenuates Th17 cell-mediated allergic skin inflammation in mice」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル